BR&L SRL
1.0 FTEThe score of BR&L shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +25 % Total assets -10 % Headcount (avg FTE) -9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BR&L's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 15,493 € | ||||
| Equity | 186,207 € | ||||
| Cash | 47,674 € | ||||
| EBITDA | 79,442 € | ||||
| Total assets | 709,410 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 20 Jun 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 14 Jun 2022
BR&L's financial analysis
- Solvency26.2%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BR&L
BR&L's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0833.713.020
- VAT number
- BE0833713020
- Peppol
- Registered · 0208:0833713020 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Feb 2011
- Registered office
- 9080 Lochristi
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of corrective glasses, lenses and sunglasses (NACE 47742)
BR&L (SRL) has been based in Lochristi since 2011, active in: retail sale of corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 15,493 € and equity of 186,207 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 26.2%, below the median of its sector (47.4%).
Companies similar to BR&L
Companies in the same business, of comparable size and area, outside its group.
- Akademiek Optiek VAN Bignoot-Houben Retail sale of medical and orthopaedic goods Ghent · balance sheet 762,340 €
- Balman Optics Retail sale of medical and orthopaedic goods Destelbergen · balance sheet 660,712 €
- Histoires D'Opticiens Retail sale of medical and orthopaedic goods La Louvière · balance sheet 707,296 €
- Optique Lucky Claes Retail sale of medical and orthopaedic goods Waremme · balance sheet 713,540 €
- Optiek D. Vleeracker Retail sale of medical and orthopaedic goods Mechelen · balance sheet 702,163 €
- Eurolook Retail sale of medical and orthopaedic goods Tielt · balance sheet 701,939 €
- D'Vine Retail sale of medical and orthopaedic goods Beringen · balance sheet 697,048 €
- Stappers P. Retail sale of medical and orthopaedic goods Mechelen · balance sheet 728,282 €
Frequently asked questions about BR&L
What is the revenue of BR&L?
BR&L files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BR&L?
In Belgium, the VAT number is the company number prefixed with BE: BE0833713020 for BR&L, if the company is VAT-registered. Its company number (CBE) is 0833.713.020.
Where is the registered office of BR&L?
According to the CBE register, the registered office of BR&L is in 9080 Lochristi.
What is the equity of BR&L?
At the close of the 2025 financial year, the equity of BR&L amounts to 186,207 €, a solvency of 26.2% of total assets.
How many people work at BR&L?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages BR&L?
The register lists 1 active mandates at BR&L. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BR&L
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →